C-MER Eye
Providing ophthalmic, general medical and surgical services.
Launch date
Market cap
$309m
Enterprise valuation
$285m (Public information from Sep 2024)
Share price
HKD2.17 3309.HK
Hong Kong Island Hong Kong (HQ)
Financials
Estimates*
| HKD | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenues | 576m | 700m | 1.1b | 1.7b | 1.9b |
| % growth | - | 21 % | 59 % | 56 % | 11 % |
| EBITDA | 139m | 123m | 176m | 266m | 366m |
| % EBITDA margin | 24 % | 18 % | 16 % | 15 % | 19 % |
| Profit | 41.4m | (6.2m) | 21.9m | (21.9m) | 62.0m |
| % profit margin | 7 % | (1 %) | 2 % | (1 %) | 3 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
* | N/A | HKD388m | Private Placement VC |
| Total Funding | $46.9m | ||
Related Content
Recent News about C-MER Eye
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by C-MER Eye
Edit
ACQUISITION by Alcon May 2024